In conclusion, our meta-analysis suggests that, compared with low VEGF expression, high VEGF expression is significantly associated with poor survival outcomes (OS, DSS), later clinical stage, poorer differentiation, and lymph node metastasis in patients with endometrial cancer. The gene discussed is VEGFA; the disease is metastatic malignant neoplasm in the lymph nodes.